benzo[b]naphtho[1,2-d]furan-10-boronic acid | CAS:1256544-74-7

We serve benzo[b]naphtho[1,2-d]furan-10-boronic acid CAS:1256544-74-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
benzo[b]naphtho[1,2-d]furan-10-boronic acid

Chemical Name:benzo[b]naphtho[1,2-d]furan-10-boronic acid
CAS.NO:1256544-74-7
Synonyms:10-BAPNF
Molecular Formula:C16H11BO3
Molecular Weight:262.06800
 
Specification:
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like benzo[b]naphtho[1,2-d]furan-10-boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,10-BAPNF physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,10-BAPNF Use and application,10-BAPNF technical grade,usp/ep/jp grade.


Related News: On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday.Dodecyltrimethoxysilane manufacturer Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.1-(2-Methylpropyl)-4-piperidone supplier Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide vendor Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.